Cannabinoids as Therapeutics - gebunden oder broschiert
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Orellfuessli.ch Nr. A1000518062. Versandkosten:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Versandfertig innert 1 - 2 Wochen, zzgl. Versandkosten. (EUR 17.67) Details... |
Cannabinoids as Therapeutics (Milestones in Drug Therapy) - gebrauchtes Buch
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
BetterWorldBooks.com used in stock. Versandkosten:zzgl. Versandkosten. Details... |
Cannabinoids As Therapeutics - gebrauchtes Buch
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
BetterWorldBooks.com used in stock. Versandkosten:zzgl. Versandkosten. Details... |
Cannabinoids as Therapeutics - gebunden oder broschiert
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Springer.com new in stock. Versandkosten:zzgl. Versandkosten. (EUR 0.00) Details... |
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Springer.com Nr. 978-3-7643-7055-8. Versandkosten:Worldwide free shipping, , DE. (EUR 0.00) Details... |
Cannabinoids as Therapeutics - gebunden oder broschiert
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Raphael Mechoulam:
Cannabinoids as Therapeutics (Milestones in Drug Therapy) - gebrauchtes BuchISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Cannabinoids As Therapeutics - gebrauchtes Buch
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Cannabinoids as Therapeutics - gebunden oder broschiert
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
ISBN: 9783764370558
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most … Mehr…
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Cannabinoids as Therapeutics (Milestones in Drug Therapy)
EAN (ISBN-13): 9783764370558
ISBN (ISBN-10): 3764370556
Gebundene Ausgabe
Erscheinungsjahr: 2005
Herausgeber: Mechoulam, Raphael, Birkhäuser
272 Seiten
Gewicht: 0,800 kg
Sprache: eng/Englisch
Buch in der Datenbank seit 2007-06-12T19:55:14+02:00 (Berlin)
Detailseite zuletzt geändert am 2024-04-30T21:53:00+02:00 (Berlin)
ISBN/EAN: 3764370556
ISBN - alternative Schreibweisen:
3-7643-7055-6, 978-3-7643-7055-8
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: marta williams, mechoulam raphael
Titel des Buches: milestones therapy, the cannabinoids, cannabinoids therapeutics, cannabinoid, raphael
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9783764373580 Cannabinoids as Therapeutics (Thierry Cazenave)
< zum Archiv...